为肝细胞癌武装 GPC3 CAR-T 细胞:多少才足够,下一步是什么?
Armouring GPC3 CAR T cells for hepatocellular carcinoma: how much is enough and what comes next?
英文原题:Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making.
Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
糖基化相关特征对 HCC 的预后识别、免疫疗效评估和物质代谢有效,为治疗靶点预测和临床决策提供了新见解。
肝细胞癌(HCC)是全球第五大常见癌症和第三大癌症死亡原因,严重影响人类社区健康和护理。新出现的证据表明,异常糖基化与肿瘤进展和转移相关。然而,糖基化相关基因在HCC中的作用尚未被报道。
采用加权基因共表达网络分析和非负矩阵分解分析鉴定HCC的功能模块和分子亚型。采用最小绝对收缩与选择算子Cox回归构建糖基化相关特征。通过主成分分析、T分布随机邻域嵌入分析、Kaplan-Meier生存分析、ROC曲线、多变量Cox回归、列线图和校准曲线等系统方法确认并验证了风险模型的独立预后价值。通过免疫微环境和潜在生物学过程评估了单样本基因集富集分析、基因集变异分析、基因本体和京都基因与基因组百科全书分析。采用实时荧光定量聚合酶链反应和免疫组织化学分析验证五个基因的表达。
我们通过生物信息学分析鉴定了糖基化相关基因,以构建并验证一个用于HCC患者预后的五基因特征。高风险组的HCC患者预后较差。风险评分可作为独立因素,并与临床特征如分级和分期相关。列线图展示了包含风险评分和临床参数的准确评分。低风险组中抗肿瘤细胞的浸润水平上调,包括B_cells、Mast_cells、中性粒细胞、NK_cells和T_helper_cells。此外,糖基化对免疫治疗更敏感,并可能在HCC的代谢过程中发挥关键作用,如胆汁酸代谢和脂肪酸代谢。另外,这五个基因的messenger RNA (mRNA)和蛋白表达在HCC细胞和组织中过表达。
Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer deaths worldwide, seriously affecting human community health and care. Emerging evidence has shown that aberrant glycosylation is associated with tumor progression and metastasis. However, the role of glycosylation-related genes in HCC has notbeen reported.
Weighted gene coexpression network analysis and non-negative matrix factorization analysis were applied to identify functional modules and molecularm subtypes in HCC. The least absolute shrinkage and selection operator Cox regression was used to construct the glycosylation-related signature. The independent prognostic value of the risk model was confirmed and validated by systematic techniques, including principal component analysis, T-distributed random neighbor embedding analysis, Kaplan-Meier survival analysis, the ROC curve, multivariate Cox regression, the nomogram, and the calibration curve. The single-sample gene set enrichment analysis, gene set variation analysis, Gene Ontology, and Kyoto Encyclopedia of Genes and Genomes analyses were evaluated by the immune microenvironment and potential biological processes. The quantitative real-time polymerase chain reaction and immunohistochemistry analysis were used to verify the expression of five genes.
We identified the glycosylation-related genes with bioinformatics analysis to construct and validate a five-gene signature for the prognosis of HCC patients. Patients with HCC in the high-risk group had a worse prognosis. The risk score could be an independent factor and was associated with clinical features, such as the grade and stage. The nomogram exhibited an accurate score that included the risk score and clinical parameters. The infiltration levels of antitumor cells were upregulated in the low-risk group, including B_cells, Mast_cells, neutrophils, NK_cells, and T_helper_cells. Moreover, glycosylation was more sensitive to immunotherapy, and may play a critical role in the metabolic processes of HCC, such as bile acid metabolism and fatty acid metabolism. In addition, the five-gene messenger RNA (mRNA) and protein expression were overexpressed in HCC cells and tissues.
The glycosylation-related signature is effective for prognostic recognition, immune efficacy evaluation, and substance metabolism in HCC, providing a novel insight for therapeutic target prediction and clinical decision-making.
MEMBER ACCOUNT
登录成功会直接打开下一页。